What laboratory tests are recommended in a patient with recurrent miscarriage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Recurrent Miscarriage

For patients with recurrent miscarriage (three or more consecutive pregnancy losses), a comprehensive panel of laboratory tests should include antiphospholipid antibodies, parental karyotyping, thyroid function tests, and complete blood count, as these address the most common treatable causes.

Essential Laboratory Tests

Immunological Testing

  • Antiphospholipid antibodies 1, 2
    • Lupus anticoagulant
    • Anticardiolipin antibodies
    • Anti-β2 glycoprotein-I antibodies
    • Consider subgroup antibodies (antiphosphatidyl-serine, -inositol, -ethanolamine, -choline, -glycerol) 3

Genetic Testing

  • Parental karyotype analysis 1, 2
  • Cytogenetic analysis of pregnancy tissue (from third and subsequent miscarriages) 2

Endocrine Testing

  • Thyroid function tests (TSH, free T4) 1, 2
  • Thyroid peroxidase (TPO) antibodies 2

Hematological Testing

  • Complete blood count with platelets 1, 4
  • Thrombophilia screening (for second trimester losses or specific indications) 2:
    • Factor V Leiden
    • Prothrombin gene mutation
    • Protein S deficiency

Additional Tests Based on Clinical Presentation

For Suspected Thrombophilia

  • Thromboelastography (TEG) - particularly if maximum amplitude (MA) ≥64 mm 1
  • Sticky platelet syndrome testing 3
  • Tissue plasminogen activator (TPA) levels 3
  • PAI-1 levels 3

For Suspected Structural Issues

  • Pelvic ultrasound (preferably 3D) 1, 2
  • Hysterosalpingogram (if 3D ultrasound not available) 4

Tests Not Routinely Recommended

  • Routine testing for protein C, antithrombin deficiency, and MTHFR mutation 2
  • Immunological screening (HLA, cytokine, natural killer cell tests) outside research settings 2
  • Infection screening (unless specific indications) 2
  • Sperm DNA testing (not routinely recommended) 2

Practical Approach to Testing

  1. First visit: Order antiphospholipid antibodies, thyroid function tests with TPO antibodies, and complete blood count
  2. Second visit: Arrange parental karyotyping and pelvic ultrasound assessment
  3. For second trimester losses: Add thrombophilia screening
  4. For pregnancy tissue: Perform cytogenetic analysis when available

Important Considerations

  • Testing should be performed prior to conception when possible 1
  • Antiphospholipid testing must be repeated after 12 weeks if positive, as this is the most common treatable cause (found in up to 67% of cases) 3
  • Parental karyotyping is especially important when pregnancy tissue shows unbalanced structural chromosomal abnormality 2
  • The timing of testing is critical - some tests (like antiphospholipid antibodies) should be done when the patient is not pregnant or on hormonal therapy

By identifying specific underlying causes through appropriate laboratory testing, targeted interventions can be implemented to improve outcomes in future pregnancies, with success rates approaching 98% for certain conditions like antiphospholipid syndrome when properly treated 3.

References

Guideline

Recurrent Miscarriage Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recurrent MiscarriageGreen-top Guideline No. 17.

BJOG : an international journal of obstetrics and gynaecology, 2023

Research

Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.